Dr. Rastinehad on Transperineal Fusion Biopsy for Prostate Cancer Focal Therapy
June 3rd 2016
Art Rastinehad, DO, Director of Focal Therapy and Interventional Urologic Oncology, Mount Sinai Health System, discusses an electromagnetically (EM) tracked transperineal MR/US fusion-guided biopsy platform (tpFBx) for prostate cancer.